Continental Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-11,174
Closed -$1.38M 140
2017
Q1
$1.38M Sell
11,174
-7,916
-41% -$937K 0.31% 85
2016
Q4
$2.1M Sell
19,090
-3,957
-17% -$440K 0.57% 62
2016
Q3
$2.72M Hold
23,047
0.76% 48
2016
Q2
$2.58M Sell
23,047
-8,148
-26% -$877K 0.8% 47
2016
Q1
$3.14M Hold
31,195
0.89% 37
2015
Q4
$3.31M Sell
31,195
-6,984
-18% -$721K 0.84% 35
2015
Q3
$3.56M Hold
38,179
0.96% 39
2015
Q2
$3.98M Sell
38,179
-1,746
-4% -$182K 1.06% 34
2015
Q1
$4.33M Sell
39,925
-32,592
-45% -$3.35M 0.95% 35
2014
Q4
$6.72M Buy
72,517
+18,042
+33% +$1.59M 1.36% 13
2014
Q3
$4.76M Buy
54,475
+5,238
+11% +$473K 1.08% 23
2014
Q2
$4.33M Hold
49,237
1.01% 28
2014
Q1
$4.15M Buy
49,237
+13,153
+36% +$1.05M 1.07% 27
2013
Q4
$2.83M Buy
+36,084
New +$3.08M 0.62% 42

Other funds holding LH

Continental Advisors's LH Position: Q2 2017 in Review

Continental Advisors sold out of Labcorp (LH) in Q2 2017, closing a stake of 11,174 shares — an estimated $1.38M sold.

Continental Advisors first reported a position in LH in Q4 2013 and held it in 14 quarters. The position peaked at $6.72M in Q4 2014. 691 funds tracked by Wall St. Rank hold LH as of Q2 2017.

  • Continental Advisors reported no remaining Labcorp position as of Q2 2017 after selling out during the quarter.
  • Continental Advisors sold 11,174 Labcorp shares in Q2 2017, an estimated $1.38M.
  • Continental Advisors first reported a position in Labcorp in Q4 2013 and held it in 14 quarters.
  • Continental Advisors's Labcorp position peaked at $6.72M in Q4 2014.
  • 691 funds tracked by Wall St. Rank held Labcorp as of Q2 2017.

Based on Continental Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.